Consumer Information Transparency
Consumer Information Transparency is a formal construct within pharmaceutical and regulatory science that denotes the systematic and accessible disclosure of inactive ingredients in drug products to end users, distinguished by its focus on empowering informed consumer decision-making through accurate, standardized, and publicly available formulation data.
104
Publications
8.2K
Citations
264
Authors
165
Institutions
Publications per year
2017–2026
67
104
1–5 of 104
264
4
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 264
165

University of Toronto
Toronto, Canada
3 h-index
3 publications
92 citations
Northeastern University
Boston, United States
3 h-index
4 publications
449 citations
University of Missouri
Columbia, United States
3 h-index
4 publications
426 citations

Hong Kong University of Science and Technology
Hong Kong, Hong Kong
3 h-index
5 publications
333 citations

University of Georgia
Athens, United States
3 h-index
5 publications
176 citations
Kent State University
Kent, United States
3 h-index
4 publications
130 citations
Carnegie Mellon University
Pittsburgh, United States
2 h-index
2 publications
125 citations

Tilburg University
Tilburg, The Netherlands
2 h-index
4 publications
89 citations
1–8 of 165
JM · 5 publications · 202 citations
5
h-index
Repository · 5 publications · 107 citations
5
h-index
3 publications · 212 citations
3
h-index
JCA · 3 publications · 151 citations
3
h-index
BPP · 2 publications · 42 citations
2
h-index
1–5